Power Law company profile

Gracell Biotechnologies

Biotech & Life Sciences · Huangpu, China · Founded 2017 · IPO 2021 Unicorn

A clinical-stage biotech company with mission to solve CAR-T industry hurdles

Valuation

$704M

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

15 investors on Gracell Biotechnologies's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

6 Dimensions Capital

Series B+ 14 investors entered at this stage

Wellington Management

Morningside

Lilly Asia Ventures

Temasek

Logos Capital

TCGX

Adage Capital

Vivo Capital

King Star Capital

Pivotal Life Sciences

OrbiMed

Exome Asset Management

RA Capital Management

Janus Henderson Investors

Global footprint

Where Gracell Biotechnologies has talent and traffic

Workforce by country

2 countries with
team presence

🇨🇳 China81.1%

🇺🇸 United States18.9%

2 countries shown

Web traffic by country

2.5K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$12M patent portfolio · 40 active families

Estimated portfolio value

$12M

1.7% of market cap · 2.2× smaller than top peer Kymera Therapeutics ($26M)

40 active patent families

Where Gracell Biotechnologies innovates BiochemistryMolecular biologyAntigen receptorImmune effectorTherapeutic effect

Where Gracell Biotechnologies concentrates vs peers

Each axis is a top-10 topic across Gracell Biotechnologies and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Gracell Biotechnologies

An AI-synthesized read of the highest-engagement posts about Gracell Biotechnologies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Gracell Biotechnologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles